Table 1.
Group A (n = 254) | Group B (n = 307) | P value | |
Sex | |||
Male | 214 (84) | 260 (85) | 0.907 |
Female | 40 (16) | 47 (15) | |
Age (yr), median (range) | 64 (39-81) | 66 (41-86) | < 0.001 |
Baseline clinical TNM-stage | |||
I | 119 (47) | 155 (50) | 0.39 |
II | 66 (26) | 88 (29) | 0.50 |
III | 69 (27) | 64 (21) | 0.09 |
Treatment for primary ESCC | |||
Surgery | 84 (33) | 124 (40) | 0.079 |
Endoscopic resection | 77 (30) | 113 (37) | 0.010 |
Chemoradiotherapy | 93 (37) | 70 (23) | 0.001 |
Follow-up period | |||
Median months (range) | 60 (13-145) | 67 (12-107) | 0.150 |
ESCC: Esophageal squamous cell carcinoma.